tirzepatide 25mg/ml dosing chart Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Tirzepatide Dosing for Weight Loss

Also available in the UAE and Oman through official partners

Corticosteroids, atypical antipsychotics, and certain immunosuppressants promote hyperglycemia and weight gain, potentially overwhelming semaglutide's benefits

Reduced Appetite: Decreased hunger is a common effect of Semaglutide and supports appetite control

Hydrate aggressively GLP-1 medications reduce thirst along with hunger

Several user-friendly apps are widely available and can provide concrete data on how your food intake matches up with your nutrient needs

In addition, GLP-1 medications target areas of the brain that regulate appetite and food cravings